ACHV News and Press, Achieve Life Sciences Inc.

2026-02-04 20:57:16 ET ... Read the full article on Seeking Alpha For further details see: Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch

2026-02-04 02:43:16 ET Intro Achieve Life Sciences ( ACHV ) is a pre-commercial, late-stage pharmaceutical company that develops a smoking and vaping cessation therapy. It currently has no sales-generating business, as it is awaiting the FDA’s decision on whether its drug...

2026-01-15 07:10:00 ET More on Disc Medicine, Sanofi, etc. Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Sanofi (SAN:CA)...

SEATTLE and VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of nicotine dependence for smoking cessation,...

2025-12-30 12:18:03 ET More on Achieve Life Sciences Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion Achieve Life Sciences outlines expedited FDA review for cytisi...

SEATTLE and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced that...

2025-11-06 15:27:12 ET More on Achieve Life Sciences Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion Achieve Life Sciences: Promising Pipeline But High Risks Makes...

2025-11-06 15:26:10 ET Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST... Read the full article on Seeking Alpha For further details see: Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript

2025-11-06 07:16:14 ET More on Achieve Life Sciences Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings...

One of Only Nine Therapies Chosen for the Inaugural FDA Commissioner’s National Priority Voucher for E-cigarette or Vaping Cessation Conference Call Scheduled for 8:30 AM EST Today, November 6, 2025 SEATTLE and VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ac...